Overview
JNJ market data
Price History
JNJ price chart
Valuation & Profitability
- P/E (TTM)
- 29.81 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $11.03 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.20 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- 2.1% Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- 21.5% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $171.81 – $274.90 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $627.2B · P/B 6.13 · P/S 6.40.
Company News
Fidelity Healthcare ETF vs. iShares Pharma Fund: Which Wins?The Motley Fool · Aug 14, 2026, 2:01 PM
Simplify's PINK or iShares' IYH: Which Healthcare ETF Should Long-Term Investors Choose Right Now?The Motley Fool · Aug 13, 2026, 8:45 PM
Cullinan Therapeutics Zipalertinib Combo Clears Key Phase 3 Hurdle As First-Line Lung Cancer Treatment Option Takes ShapeBenzinga · Aug 13, 2026, 3:21 PM
The U.S. Labor Market Is Weakening. These 2 Dividend Stocks Look Built to Weather a RecessionThe Motley Fool · Aug 11, 2026, 10:15 PM
Trump Says Administration Recognizing Childhood Vaccine Recommendations For Only 11 Core Vaccinations; Hepatitis B, COVID-19, Influenza No Longer Recommended For All ChildrenBenzinga · Aug 10, 2026, 7:00 PM
Jim Cramer Calls This Industrial Stock ‘Sensational’ And Ameriprise Financial ‘Fantastic’Benzinga · Aug 7, 2026, 12:14 PM
Worried About the Market? These Stocks Have a Track Record of Helping Investors Sleep at Night.The Motley Fool · Aug 6, 2026, 3:02 PM
Guggenheim Maintains Buy on Johnson & Johnson, Raises Price Target to $287Benzinga · Aug 6, 2026, 1:22 PM
Kathy Hochul Slams Trump Over Medicare Cut, Says 1.3 Million New Yorkers Will Pay More for Prescriptions: 'A New Assault on Seniors...'Benzinga · Aug 6, 2026, 7:41 AM
State Street XLV vs VanEck BBH: Which Healthcare ETF Is the Better Buy in 2026?The Motley Fool · Aug 5, 2026, 8:15 PM